152 related articles for article (PubMed ID: 1564837)
1. [Sequential methotrexate and 5-fluorouracil, doxorubicin, and cisplatin for advanced urothelial cancer].
Nishiyama T; Sasagawa T; Tanikawa T; Katayama Y; Kawakami Y; Tomita Y; Terunuma M; Kimura M; Sato S; Osawa T
Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):352-7. PubMed ID: 1564837
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Ahmed T; Weiselberg LR; Geller N; Hollander PS; Herr HW; Sogani PC
J Urol; 1985 Mar; 133(3):403-7. PubMed ID: 4038749
[TBL] [Abstract][Full Text] [Related]
3. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
[TBL] [Abstract][Full Text] [Related]
5. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Kobayashi H; Obata K
Cancer Chemother Pharmacol; 1994; 35 Suppl():S14-7. PubMed ID: 7994781
[TBL] [Abstract][Full Text] [Related]
6. [Clinical results of IV-compa (cisplatin, vincristine, methotrexate, peplomycin and adriamycin) chemotherapy for advanced urothelial cancer].
Tsujino S; Ono Y; Yamamoto S; Tsuzuki M; Miki M; Aizawa T; Matsumoto T; Yamauchi T
Nihon Hinyokika Gakkai Zasshi; 1995 Jun; 86(6):1164-71. PubMed ID: 7609360
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.
Oh WK; Manola J; Richie JP; Loughlin KR; Kantoff PW
Cancer; 1999 Oct; 86(7):1329-34. PubMed ID: 10506721
[TBL] [Abstract][Full Text] [Related]
8. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Igawa M; Kadena H; Ueda M; Usui T
Cancer Chemother Pharmacol; 1994; 35 Suppl():S1-4. PubMed ID: 7527732
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
[TBL] [Abstract][Full Text] [Related]
10. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience.
Tannock I; Gospodarowicz M; Connolly J; Jewett M
J Urol; 1989 Aug; 142(2 Pt 1):289-92. PubMed ID: 2746745
[TBL] [Abstract][Full Text] [Related]
11. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Kume T; Masu C; Ishino T; Nakatsu H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
[TBL] [Abstract][Full Text] [Related]
12. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
Lerner SE; Blute ML; Richardson RL; Zincke H
Mayo Clin Proc; 1996 Oct; 71(10):945-50. PubMed ID: 8820768
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
Kyriakakis Z; Dimopoulos MA; Kostakopoulos A; Karayiannis A; Sofras F; Zervas A; Giannopoulos A; Dimopoulos C
J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313
[TBL] [Abstract][Full Text] [Related]
14. Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer.
Bellmunt J; Cos J; Clèries R; Pérez M; Ribas A; Eres N; Murio JE; Margarit C; Baselga J
Cancer Invest; 2002; 20(5-6):673-85. PubMed ID: 12197223
[TBL] [Abstract][Full Text] [Related]
15. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
[No Abstract] [Full Text] [Related]
16. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS
J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
[TBL] [Abstract][Full Text] [Related]
17. [Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter].
Shishido S; Hayakawa M; Higa I; Koyama Y; Hatano T; Osawa A
Hinyokika Kiyo; 1990 Apr; 36(4):401-5. PubMed ID: 2378303
[TBL] [Abstract][Full Text] [Related]
18. Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response.
Igawa M; Urakami S; Shiina H; Ishibe T; Kadena H; Usui T
Br J Urol; 1995 Sep; 76(3):321-4. PubMed ID: 7551840
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
Hashimura T; Okumura K; Akao T; Nakagawa T
Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
